Admixture Mapping of Preterm Birth Genes
Admixture Mapping of Preterm Birth Genes
批准号:
8790255
负责人:
JEROME F STRAUSS
金额:
$8.3万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-15 至 2016-06-30
关键词:
AdmixtureAfricanAfrican AmericanAllelesAmericanBirthBirth RateCandidate Disease GeneChromosomes, Human, Pair 2Chromosomes, Human, Pair 21DataDeveloped CountriesEarly InterventionEpigenetic ProcessEuropeanExclusionFunctional disorderGenesGeneticGenetic MarkersGenetic RiskGenetic VariationGenomeGenotypeGoalsHealthcare SystemsIncidenceIndividualKnowledgeLeadLife StyleLinkMapsMedicalMicroRNAsNeonatalOutcomePathologic ProcessesPregnancyPregnancy ComplicationsPremature BirthPrevention strategyResearchRiskRisk FactorsSamplingTestingTherapeutic InterventionUnited StatesVariantWomanbasecostdisabilityexome sequencingexpectationexperiencefetalgene discoverygenetic varianthealth disparityinnovationneonateprematurepreterm premature rupture of membranesprevention clinical trialracial and ethnic disparitiestransmission process
中文摘要
早产是美国最重要的医疗问题之一,花费了美国的医疗保健
系统每年超过260亿美元。此外,在种族和族裔方面存在着重大的差异。
早产的发生率,非洲裔美国妇女经历了不成比例的高数字
与欧美女性相比,早产。虽然这种差异的基础可能是多因素的,
越来越多的证据表明,遗传变异和基因环境
相互作用有助于
非裔美国人早产的风险增加。一种方法来阐明风险因素的差异,
早产,并确定治疗干预的目标,是寻找相关的基因,
或与这一结果有关。遗传标记可用于前瞻性地识别可能受益的受试者
早期干预。预测早产的标记物也可以促进和减少预防费用
临床试验通过识别高风险
个体和排除低风险受试者。最后,基因
标记物可以改善对分娩的正常和病理过程的理解,
导致基于贡献基因的创新医学治疗。这三个具体目标,
应用程序代表了一种客观的方法,以确定早产基因,有助于种族/种族
差距。重点将是早产胎膜早破(PPROM),主要可识别的
早产和妊娠并发症的原因,这是更常见的非洲裔美国人。
我们提出
1)通过混合作图(AM)鉴定导致PPROM的基因座。这一具体目标的基础是
期望有基因使重要的祖先特异性
增加PPROM风险。的
要检验的假设是非洲血统等位基因以及欧洲血统等位基因混合成一个
非洲血统背景有助于PPROM的风险。换句话说,祖先和混合物可以
两者都对早产有贡献。2)通过外显子组识别位于AM峰下的候选遗传变体
测序确定AM峰中可能导致PPROM的遗传变异,以及
我们将选择50例新生儿病例和50例新生儿对照,他们的非洲血统相似(70 - 80%),
用于确定AM峰的染色体区域的外显子组测序。假设是
测试的是:1)染色体2、8、11、19和21上的胎儿基因组中的基因座赋予PPROM增加的风险2)
21号染色体上的基因座在特定人群中赋予PPROM的风险和保护作用
3)遗传风险
基因座可以通过表观遗传机制(microRNA)起作用以促进PPROM。3)测试候选变体
使用传递不平衡检验(TDT)与PPROM的连锁和关联。本具体目标
目的是测试来自胎儿(新生儿)AM和外显子组中鉴定的区域的候选遗传变异
测序以确定它们是否与PPROM相关和连锁,从而赋予风险或保护。
英文摘要
Prematurity is one of the most significant medical issues in the United States, costing the American health care
system more than 26 billion dollars annually. Moreover, there are significant racial/ethnic disparities in the
incidence of preterm birth, with African American women experiencing a disproportionately higher number
preterm deliveries compared to European American women. Although the basis for this disparity is likely multifactorial,
there is increasing evidence that genetic variation and geneenvironment
interaction contribute to the
increased risk of preterm birth in African Americans. One approach to elucidate risk factors for the disparity in
prematurity, and also to identify targets for therapeutic intervention, is to search for genes that are associated
or linked to this outcome. Genetic markers could be used to identify subjects prospectively who might benefit
from early interventions. Markers predicting prematurity could also facilitate and reduce the cost of prevention
clinical trials through identification of highrisk
individuals and exclusion of low risk subjects. Finally, genetic
markers could refine understanding of the normal as well as pathologic processes underlying parturition, and
lead to innovative medical treatments based on contributing genes. The three Specific Aims proposed in this
application represent an objective approach to identifying prematurity genes that contribute to ethnic/racial
disparities. The focus will be on preterm premature rupture of membranes (PPROM), the leading identifiable
cause of preterm birth and a pregnancy complication that is more frequent in AfricanAmericans.
We propose
to: 1) Identify loci contributing to PPROM by admixture mapping (AM). This Specific Aim is grounded in the
expectation that there are genes that make significant ancestryspecific
contributions to risk of PPROM. The
hypothesis to be tested is that African ancestry alleles as well as European ancestry alleles admixed into an
African ancestry background contribute to risk of PPROM. Stated another way, ancestry and admixture can
both make contributions to prematurity. 2) Identify candidate genetic variants lying under AM peaks by exome
sequencing. To identify genetic variation in the AM peaks that potentially contribute to PPROM, as well as
refine the AM, we will select 50 neonate cases and 50 neonate controls, whose African ancestry is similar (7080%),
for exome sequencing of chromosomal regions underlying confirmed AM peaks. The hypotheses to be
tested are: 1) Loci in the fetal genome on chromosomes 2,8,11,19 and 21 confer increased risk for PPROM; 2)
Loci on chromosome 21 confer risk and protection for PPROM in a populationspecific
manner; 3) Risk genetic
loci may act through epigenetic mechanisms (microRNAs) to promote PPROM. 3) Test candidate variants for
linkage and association with PPROM using the transmission disequilibrium test (TDT). The goal of this Specific
Aim is to test candidate genetic variants from regions identified in the fetal (neonatal) AM and exome
sequencing to determine if they are in association and linkage with PPROM, conferring risk or protection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VCU NIMHD Comprehensive Center of Excellence (Project 1; PI: Strauss)
-
批准号:8655802
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2014
-
负责人:JEROME F STRAUSS
-
依托单位:
Admixture Mapping of Preterm Birth Genes
-
批准号:8531310
-
项目类别:
-
资助金额:$27.05万
-
财政年份:2012
-
负责人:JEROME F STRAUSS
-
依托单位:
Admixture Mapping of Preterm Birth Genes
-
批准号:8696875
-
项目类别:
-
资助金额:$43.99万
-
财政年份:2012
-
负责人:JEROME F STRAUSS
-
依托单位:
Admixture Mapping of Preterm Birth Genes
-
批准号:8348211
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2012
-
负责人:JEROME F STRAUSS
-
依托单位:
Admixture Mapping of Preterm Birth Genes
-
批准号:8906535
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2012
-
负责人:JEROME F STRAUSS
-
依托单位:
Admixture Mapping of Preterm Birth Genes
-
批准号:9093819
-
项目类别:
-
资助金额:$25.82万
-
财政年份:2012
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU NIMHD Comprehensive Center of Excellence (Project 1; PI: Strauss)
-
批准号:8354914
-
项目类别:
-
资助金额:$26.67万
-
财政年份:2011
-
负责人:JEROME F STRAUSS
-
依托单位:
Mechanisms of Fetal Membrane Rupture
-
批准号:8055258
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2010
-
负责人:JEROME F STRAUSS
-
依托单位:
Mechanisms of Fetal Membrane Rupture
-
批准号:7863904
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2009
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU Building Interdisciplinary Research Careers in Women's Health
-
批准号:7503396
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
National Center on Minority Health and Health Disparities-Center
-
批准号:7620865
-
项目类别:
-
资助金额:$135.62万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU NIMHD Comprehensive Center of Excellence
-
批准号:9071427
-
项目类别:
-
资助金额:$122.29万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
National Center on Minority Health and Health Disparities-Center
-
批准号:7828170
-
项目类别:
-
资助金额:$134.74万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU NIMHD Comprehensive Center of Excellence
-
批准号:8264256
-
项目类别:
-
资助金额:$124.93万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU NIMHD Comprehensive Center of Excellence
-
批准号:8655800
-
项目类别:
-
资助金额:$124.82万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU NIMHD Comprehensive Center of Excellence
-
批准号:9145938
-
项目类别:
-
资助金额:$4.51万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU NIMHD Comprehensive Center of Excellence
-
批准号:9247902
-
项目类别:
-
资助金额:$5.06万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
VCU NIMHD Comprehensive Center of Excellence
-
批准号:8470228
-
项目类别:
-
资助金额:$116.77万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
National Center on Minority Health and Health Disparities-Center
-
批准号:7494638
-
项目类别:
-
资助金额:$138.06万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
National Center on Minority Health and Health Disparities-Center
-
批准号:7277056
-
项目类别:
-
资助金额:$141.55万
-
财政年份:2007
-
负责人:JEROME F STRAUSS
-
依托单位:
海外基金